RE:RE:UpdateYes, agree, whatever they present going forward has to be grounded in a clearer path to revenue visibility.
I for one want to see them be operationally profitable, or on their way, so that:
1. We never have to worry about dilution ever again
2. There is more money going into pipelines to run clinicals and bring them to advanced license ready, and not administration
3. Sufficient funds to transition to a next generation CEO
4. To actually take a different strategy than just waiting for the next big pharma to come along. They could have bought a few Macdonalds from the outset and used that Big Mac profit to fund the pipelines, and had something more than status quo.
As we wait for the 1067 agreement to make them profitable, they have two choices, either wait around and pretend they are working or actually try something new. I for one have told them they should be selling laboratory services as "service" to help pay for lab equipment and staff. Geraldine is a world class scientist, who wouldn't pay.
As Elon Musk says, if you want to be successful, you have to be willing to sleep on the shop floor a few days a week.
They have both human and scientific capital/assets that are unexploited, and that should be put to work in full form in my opinion.